semaglutide efecto rebote Ozempic no se salva del 'efecto rebote' Los fármacos antiobesidad tipo Ozempic

Semaglutide is the active ingredient in Ozempic, which is approved by the Food and Drug Administration (FDA) to help people with type 2 diabetes manage their blood sugar levels

Patients taking Semaglutide often notice a significant decrease in appetite and an increased feeling of fullness after eating a small amount of food

Appetite suppression happens immediately because semaglutide activates brain receptors within hours, but scale weight reflects cumulative calorie deficit over days

Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, Apostolopoulos V, Stojanovska L (2021) Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19

International journal of dermatology, 60(12), 14491461

If you are considering discontinuing GLP-1s, its essential to understand the potential consequences and how to navigate them